2nox

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="2nox" size="350" color="white" frame="true" align="right" spinBox="true" caption="2nox, resolution 2.400&Aring;" /> '''Crystal structure o...)
Line 4: Line 4:
==Overview==
==Overview==
-
The structure of tryptophan 2,3-dioxygenase (TDO) from Ralstonia, metallidurans was determined at 2.4 A. TDO catalyzes the irreversible, oxidation of l-tryptophan to N-formyl kynurenine, which is the initial, step in tryptophan catabolism. TDO is a heme-containing enzyme and is, highly specific for its substrate l-tryptophan. The structure is a, tetramer with a heme cofactor bound at each active site. The monomeric, fold, as well as the heme binding site, is similar to that of the large, domain of indoleamine 2,3-dioxygenase, an enzyme that catalyzes the same, reaction except with a broader substrate tolerance. Modeling of the, putative (S)-tryptophan hydroperoxide intermediate into the active site, as well as substrate analogue and mutagenesis studies, are consistent with, a Criegee mechanism for the reaction.
+
The structure of tryptophan 2,3-dioxygenase (TDO) from Ralstonia metallidurans was determined at 2.4 A. TDO catalyzes the irreversible oxidation of l-tryptophan to N-formyl kynurenine, which is the initial step in tryptophan catabolism. TDO is a heme-containing enzyme and is highly specific for its substrate l-tryptophan. The structure is a tetramer with a heme cofactor bound at each active site. The monomeric fold, as well as the heme binding site, is similar to that of the large domain of indoleamine 2,3-dioxygenase, an enzyme that catalyzes the same reaction except with a broader substrate tolerance. Modeling of the putative (S)-tryptophan hydroperoxide intermediate into the active site, as well as substrate analogue and mutagenesis studies, are consistent with a Criegee mechanism for the reaction.
==About this Structure==
==About this Structure==
Line 15: Line 15:
[[Category: Tryptophan 2,3-dioxygenase]]
[[Category: Tryptophan 2,3-dioxygenase]]
[[Category: Bale, S.]]
[[Category: Bale, S.]]
-
[[Category: Begley, T.P.]]
+
[[Category: Begley, T P.]]
-
[[Category: Crane, B.R.]]
+
[[Category: Crane, B R.]]
-
[[Category: Ealick, S.E.]]
+
[[Category: Ealick, S E.]]
-
[[Category: Kang, S.A.]]
+
[[Category: Kang, S A.]]
[[Category: Mukherjee, T.]]
[[Category: Mukherjee, T.]]
[[Category: Zhang, Y.]]
[[Category: Zhang, Y.]]
Line 25: Line 25:
[[Category: heme protein]]
[[Category: heme protein]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jan 29 20:57:02 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:09:16 2008''

Revision as of 16:09, 21 February 2008


2nox, resolution 2.400Å

Drag the structure with the mouse to rotate

Crystal structure of tryptophan 2,3-dioxygenase from Ralstonia metallidurans

Overview

The structure of tryptophan 2,3-dioxygenase (TDO) from Ralstonia metallidurans was determined at 2.4 A. TDO catalyzes the irreversible oxidation of l-tryptophan to N-formyl kynurenine, which is the initial step in tryptophan catabolism. TDO is a heme-containing enzyme and is highly specific for its substrate l-tryptophan. The structure is a tetramer with a heme cofactor bound at each active site. The monomeric fold, as well as the heme binding site, is similar to that of the large domain of indoleamine 2,3-dioxygenase, an enzyme that catalyzes the same reaction except with a broader substrate tolerance. Modeling of the putative (S)-tryptophan hydroperoxide intermediate into the active site, as well as substrate analogue and mutagenesis studies, are consistent with a Criegee mechanism for the reaction.

About this Structure

2NOX is a Single protein structure of sequence from Cupriavidus metallidurans with as ligand. Active as Tryptophan 2,3-dioxygenase, with EC number 1.13.11.11 Full crystallographic information is available from OCA.

Reference

Crystal structure and mechanism of tryptophan 2,3-dioxygenase, a heme enzyme involved in tryptophan catabolism and in quinolinate biosynthesis., Zhang Y, Kang SA, Mukherjee T, Bale S, Crane BR, Begley TP, Ealick SE, Biochemistry. 2007 Jan 9;46(1):145-55. PMID:17198384

Page seeded by OCA on Thu Feb 21 18:09:16 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools